Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease.
Knebel W, Rao N, Uchimura T, Mori A, Fisher J, Gastonguay MR, Chaikin P.
J Clin Pharmacol. 2011 Dec 12. [Epub ahead of print]
Related citations
Aripiprazole Associated With Acute Dystonia, Akathisia, and Parkinsonism in a Single Patient.
Saddichha S, Kumar R, Babu GN, Chandra P.
J Clin Pharmacol. 2011 Sep 8. [Epub ahead of print] No abstract available.
The monoamine oxidase type B inhibitor rasagiline in the treatment of Parkinson disease: is tyramine a challenge?
Chen JJ, Wilkinson JR.
J Clin Pharmacol. 2012 May;52(5):620-8. Epub 2011 May 31.
Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson's Disease.
Chen C, Cowles VE, Sweeney M, Stolyarov ID, Illarioshkin SN.
J Clin Pharmacol. 2011 May 24. [Epub ahead of print]
Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS.
Goldstein DS, Holmes C, Sewell L, Pechnik S, Kopin IJ.
J Clin Pharmacol. 2011 Jan;51(1):66-74. Epub 2010 Mar 10.
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Goren T, Adar L, Sasson N, Weiss YM.
J Clin Pharmacol. 2010 Dec;50(12):1420-8. Epub 2010 May 5.
Population pharmacokinetic analysis of istradefylline in healthy subjects and in patients with Parkinson's disease.
J Clin Pharmacol. 2011 Jan;51(1):40-52. Epub 2010 Mar 3.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on